Anupam Rasayan India Ltd. (ANURAS) fundamentals
Anupam Rasayan India Ltd. is a listed company in Chemicals & Petrochemicals, part of the Chemicals sector, listed on the NSE as ANURAS (ISIN INE930P01018). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Anupam Rasayan India Ltd. does
Anupam Rasayan India Ltd. is an India-based company, which is engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals. The Company's segments include Life Science related Specialty Chemicals and Other Specialty Chemicals. The Life Science related Specialty Chemicals segment includes agrochemicals (including crop protection), personal care, and pharmaceuticals businesses. Its agrochemicals business includes manufacturing agro intermediates and active ingredients, such as insecticides, fungicides, herbicides and plant growth regulators. Its personal care business manufactures antibacterial and ultraviolet protection intermediates. Its pharmaceuticals business develops intermediates and key starting materials for active pharmaceutical ingredients used in therapeutic segments, including cardiovascular and antidiabetic. The Other Specialty Chemicals segment includes specialty pigments, specialty dyes, and polymer additives. It caters to Indian and global customers.
Valuation and market data
| Last close | ₹1124.50 |
|---|---|
| Market capitalisation | ₹16,558 crore |
| Enterprise value | ₹16,947 crore |
| P/E (TTM) | 74.52 |
| Price to book | 3.58 |
| Price to sales (TTM) | 3.86 |
| Book value per share | ₹314.43 |
| Dividend yield | 13.34% |
| Sector | Chemicals |
| Industry | Chemicals & Petrochemicals |
| Listed since | Wed Mar 24 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹1,696 crore | ₹171 crore | ₹161 crore | 14.32 |
| Mar 2025 | ₹909 crore | ₹81 crore | ₹73 crore | 6.62 |
| Mar 2024 | ₹1,155 crore | ₹174 crore | ₹117 crore | 10.84 |
| Mar 2023 | ₹1,286 crore | ₹242 crore | ₹169 crore | 16.25 |
| Mar 2022 | ₹1,081 crore | ₹220 crore | ₹151 crore | 15.08 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Sep 2026:
| Promoters | 59.1% |
|---|---|
| Foreign institutions (FII) | 8.7% |
| Mutual funds | 0.4% |
| Other domestic institutions | 1.8% |
| Retail and others | 30.0% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.